美国 · SEC FORM 4
ESTABLISHMENT LABS HOLDINGS INC.
ESTA · Nasdaq · CIK 0001688757 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
42 同一窗口内观察到的 Form 4 交易行
21 sales · 21 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-14 · LEWIN NICHOLAS SHERIDAN.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,982,907
- 上期报告
- 4,386,350
- 日均成交量
- 329,828
- 回补天数
- 12.1
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-14 | LEWIN NICHOLAS SHERIDAN | 买入 (P) | Common Shares | 2,600 | USD 37.85 | USD 98,410 | SEC 申报 ↗ |
| 2025-08-13 | LEWIN NICHOLAS SHERIDAN | 买入 (P) | Common Shares | 2,300 | USD 34.30 | USD 78,890 | SEC 申报 ↗ |
| 2025-08-11 | Caldini Filippo | 买入 (P) | Common Shares | 2,850 | USD 35.20 | USD 100,320 | SEC 申报 ↗ |
| 2025-08-11 | Caldini Filippo | 买入 (P) | Common Shares | 2,850 | USD 35.20 | USD 100,320 | SEC 申报 ↗ |
| 2023-12-14 | LEWIN NICHOLAS SHERIDAN | 买入 (P) | Common Shares | 2,000 | USD 27.04 | USD 54,079 | SEC 申报 ↗ |
| 2023-11-20 | LEWIN NICHOLAS SHERIDAN | 买入 (P) | Common Shares | 5,000 | USD 22.00 | USD 110,000 | SEC 申报 ↗ |
| 2023-11-17 | Denhoy Raj | 买入 (P) | Common Shares | 2,250 | USD 22.21 | USD 49,972 | SEC 申报 ↗ |
| 2023-08-15 | LEWIN NICHOLAS SHERIDAN | 买入 (P) | Common Shares | 400 | USD 56.13 | USD 22,452 | SEC 申报 ↗ |
| 2022-05-13 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Shares | 5,000 | USD 54.83 | USD 274,150 | SEC 申报 ↗ |
| 2022-05-09 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Shares | 10,000 | USD 57.52 | USD 575,200 | SEC 申报 ↗ |
| 2022-04-13 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Shares | 35,000 | USD 70.01 | USD 2,450,350 | SEC 申报 ↗ |
| 2022-03-14 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Shares | 10,000 | USD 52.63 | USD 526,300 | SEC 申报 ↗ |
| 2022-03-02 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Shares | 5,000 | USD 59.45 | USD 297,250 | SEC 申报 ↗ |
| 2022-02-28 | J.W. Opportunities Master Fund, Ltd.; JW Asset Management, LLC; JW GP, LLC; JW Partners, LP; Wild Jason G. | 买入 (P) | Common Stock | 10,000 | USD 59.42 | USD 594,200 | SEC 申报 ↗ |
| 2021-11-24 | SCHUTTER EDWARD J | 买入 (P) | Common Shares | 30,000 | USD 67.00 | USD 2,010,000 | SEC 申报 ↗ |
Form 4 申报证据
63 transaction lines in the latest 365-day window; 282 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Slotkin Bryan | 奖励/授予 (A) | Common Shares | 253 | USD 64.17 | USD 16,235 | SEC 申报 ↗ |
| 2026-09-30 | SCHUTTER EDWARD J | 奖励/授予 (A) | Common Shares | 253 | USD 64.17 | USD 16,235 | SEC 申报 ↗ |
| 2026-09-30 | LEWIN NICHOLAS SHERIDAN | 奖励/授予 (A) | Common Shares | 389 | USD 64.17 | USD 24,962 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Slotkin Bryan | 奖励/授予 (A) | Common Shares | 253 | USD 64.17 | USD 16,235 | SEC 申报 ↗ |
| 2026-09-30 | SCHUTTER EDWARD J | 奖励/授予 (A) | Common Shares | 253 | USD 64.17 | USD 16,235 | SEC 申报 ↗ |
| 2026-09-30 | LEWIN NICHOLAS SHERIDAN | 奖励/授予 (A) | Common Shares | 389 | USD 64.17 | USD 24,962 | SEC 申报 ↗ |
| 2026-09-30 | Gillin Leslie | 奖励/授予 (A) | Common Shares | 262 | USD 64.17 | USD 16,813 | SEC 申报 ↗ |
| 2026-09-30 | Custin Ann | 奖励/授予 (A) | Common Shares | 301 | USD 64.17 | USD 19,315 | SEC 申报 ↗ |
| 2026-08-20 | Caldini Filippo | 代扣税 (F) | Common Shares | 682 | USD 71.52 | USD 48,777 | SEC 申报 ↗ |
| 2026-06-30 | Slotkin Bryan | 奖励/授予 (A) | Common Shares | 189 | USD 85.81 | USD 16,218 | SEC 申报 ↗ |
| 2026-06-30 | SCHUTTER EDWARD J | 奖励/授予 (A) | Common Shares | 216 | USD 85.81 | USD 18,535 | SEC 申报 ↗ |
| 2026-06-30 | LEWIN NICHOLAS SHERIDAN | 奖励/授予 (A) | Common Shares | 291 | USD 85.81 | USD 24,971 | SEC 申报 ↗ |
| 2026-06-30 | Gillin Leslie | 奖励/授予 (A) | Common Shares | 196 | USD 85.81 | USD 16,819 | SEC 申报 ↗ |
| 2026-06-30 | Custin Ann | 奖励/授予 (A) | Common Shares | 239 | USD 85.81 | USD 20,509 | SEC 申报 ↗ |
| 2026-06-24 | Harris Taylor C. | 奖励/授予 (A) | Common Shares | 3,722 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-24 | Harris Taylor C. | 奖励/授予 (A) | Common Shares | 3,230 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 65,100 | USD 72.89 | USD 4,745,139 | SEC 申报 ↗ |
| 2026-05-27 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 113 | USD 72.50 | USD 8,192 | SEC 申报 ↗ |
| 2026-05-26 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 25,320 | USD 74.39 | USD 1,883,555 | SEC 申报 ↗ |
| 2026-05-22 | Slotkin Bryan | 奖励/授予 (A) | Common Shares | 2,354 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | SCHUTTER EDWARD J | 奖励/授予 (A) | Common Shares | 2,354 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | LEWIN NICHOLAS SHERIDAN | 奖励/授予 (A) | Common Shares | 2,354 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | Gillin Leslie | 奖励/授予 (A) | Common Shares | 2,354 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | Custin Ann | 奖励/授予 (A) | Common Shares | 2,354 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 16,999 | USD 71.40 | USD 1,213,729 | SEC 申报 ↗ |
| 2026-05-20 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 3,580 | USD 70.56 | USD 252,605 | SEC 申报 ↗ |
| 2026-05-06 | JW Asset Management, LLC; JW GP, LLC; JW Opportunities Fund, LLC; JW Partners, LP; Wild Jason G. | 卖出 (S) | Common Shares | 60,000 | USD 75.63 | USD 4,537,800 | SEC 申报 ↗ |
| 2026-05-06 | Chacon Quiros Juan Jose | 卖出 (S) | Common Shares | 105,000 | USD 75.42 | USD 7,918,731 | SEC 申报 ↗ |
| 2026-05-04 | Chacon Quiros Juan Jose | 卖出 (S) | Common Shares | 7,751 | USD 70.48 | USD 546,300 | SEC 申报 ↗ |
| 2026-05-01 | Chacon Quiros Juan Jose | 卖出 (S) | Common Shares | 67,249 | USD 70.78 | USD 4,759,549 | SEC 申报 ↗ |
| 2026-04-27 | Chacon Quiros Juan Jose | 卖出 (S) | Common Shares | 2,180 | USD 66.26 | USD 144,441 | SEC 申报 ↗ |
| 2026-04-24 | Chacon Quiros Juan Jose | 奖励/授予 (A) | Common Shares | 11,315 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-24 | Chacon Quiros Juan Jose | 卖出 (S) | Common Shares | 30,178 | USD 65.78 | USD 1,985,044 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ESTA |
| CIK | 0001688757 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 282 transaction lines from 2020-05-13 to 2026-09-30 25 P purchase lines · 105 S sale lines · 152 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.